BACKGROUND: The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications(EDIC) studies have established multiyear mean hemoglobin A1c (HbA1c) as predictive of microvascular complications in persons with type 1 diabetes. However, multiyear mean HbA1c is not always available in the clinical setting. Skin advanced glycation end products (AGEs) are thought to partially reflect effects of hyperglycemia over time, and measurement of skin AGEs might be a surrogate for multiyear mean HbA1c. As certain AGEs fluoresce and skin fluorescence has been demonstrated to correlate with the concentration of skin AGEs, noninvasive measurement by skin intrinsic fluorescence(SIF) facilitates the exploration of the association of mean HbA1c and other clinical/technical factors with SIF using the detailed phenotypic database available in DCCT/EDIC. SUBJECTS AND METHODS: Of the subjects, 1,185 (53% male) had measurements of SIF during years 16/17 of EDIC with mean age and diabetes duration of 51.5 and 29.8 years, respectively. SIF measurements were obtained on the underside of the forearm near the elbow using a skin fluorescence spectrometer. Demographic data and health history were self-reported, and an annual standardized examination measured clinical status. Linear regression models were constructed to identify significant clinical and technical factors associated with SIF, and the final models only used factors that were significant. RESULTS: SIF ranged from 8.7 to 54.0 arbitrary units and was log-normally distributed. Log(SIF) correlated more with mean HbA1c as the time period increased. In multivariate analyses log(SIF) was significantly associated with mean HbA1c, age,estimated glomerular filtration rate < 60mL/min/m2, smoking status, skin tone, and clinic latitude <37 N. CONCLUSIONS:SIF reflects age, mean HbA1c over time, smoking, and renal damage, which are known risk factors for diabetes complications.
RCT Entities:
BACKGROUND: The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications(EDIC) studies have established multiyear mean hemoglobin A1c (HbA1c) as predictive of microvascular complications in persons with type 1 diabetes. However, multiyear mean HbA1c is not always available in the clinical setting. Skin advanced glycation end products (AGEs) are thought to partially reflect effects of hyperglycemia over time, and measurement of skin AGEs might be a surrogate for multiyear mean HbA1c. As certain AGEs fluoresce and skin fluorescence has been demonstrated to correlate with the concentration of skin AGEs, noninvasive measurement by skin intrinsic fluorescence(SIF) facilitates the exploration of the association of mean HbA1c and other clinical/technical factors with SIF using the detailed phenotypic database available in DCCT/EDIC. SUBJECTS AND METHODS: Of the subjects, 1,185 (53% male) had measurements of SIF during years 16/17 of EDIC with mean age and diabetes duration of 51.5 and 29.8 years, respectively. SIF measurements were obtained on the underside of the forearm near the elbow using a skin fluorescence spectrometer. Demographic data and health history were self-reported, and an annual standardized examination measured clinical status. Linear regression models were constructed to identify significant clinical and technical factors associated with SIF, and the final models only used factors that were significant. RESULTS: SIF ranged from 8.7 to 54.0 arbitrary units and was log-normally distributed. Log(SIF) correlated more with mean HbA1c as the time period increased. In multivariate analyses log(SIF) was significantly associated with mean HbA1c, age,estimated glomerular filtration rate < 60mL/min/m2, smoking status, skin tone, and clinic latitude <37 N. CONCLUSIONS: SIF reflects age, mean HbA1c over time, smoking, and renal damage, which are known risk factors for diabetes complications.
Authors: Saul Genuth; Wanjie Sun; Patricia Cleary; David R Sell; William Dahms; John Malone; William Sivitz; Vincent M Monnier Journal: Diabetes Date: 2005-11 Impact factor: 9.461
Authors: Yuen-Fung Yiu; Yap-Hang Chan; Kai-Hang Yiu; Chung-Wah Siu; Sheung-Wai Li; Lai-Yung Wong; Stephen W L Lee; Sidney Tam; Eric W K Wong; Bernard M Y Cheung; Hung-Fat Tse Journal: J Clin Endocrinol Metab Date: 2011-02-16 Impact factor: 5.958
Authors: R Meerwaldt; R Graaff; P H N Oomen; T P Links; J J Jager; N L Alderson; S R Thorpe; J W Baynes; R O B Gans; A J Smit Journal: Diabetologia Date: 2004-07-09 Impact factor: 10.122
Authors: Barbara H Braffett; Gayle M Lorenzi; Catherine C Cowie; Xiaoyu Gao; Kathleen E Bainbridge; Karen J Cruickshanks; John R Kramer; Rose A Gubitosi-Klug; Mary E Larkin; Annette Barnie; John M Lachin; David S Schade Journal: Endocr Pract Date: 2019-08-14 Impact factor: 3.443
Authors: Barbara E K Klein; Kayla L Horak; John D Maynard; Kristine E Lee; Ronald Klein Journal: Ophthalmic Epidemiol Date: 2017-03-13 Impact factor: 1.648
Authors: Ronald Klein; Kristine E Lee; John D Maynard; Stacy M Meuer; Ronald E Gangnon; Barbara E K Klein Journal: Invest Ophthalmol Vis Sci Date: 2017-12-01 Impact factor: 4.799
Authors: Erin L Tomaszewski; Trevor J Orchard; Marquis Hawkins; Baqiyyah N Conway; Jeanine M Buchanich; John Maynard; Thomas Songer; Tina Costacou Journal: J Diabetes Complications Date: 2020-10-23 Impact factor: 2.852
Authors: Erin L Tomaszewski; Trevor J Orchard; Marquis S Hawkins; Rebecca B N Conway; Jeanine M Buchanich; John Maynard; Thomas Songer; Tina Costacou Journal: J Diabetes Sci Technol Date: 2021-05-15
Authors: Trevor J Orchard; Timothy J Lyons; Patricia A Cleary; Barbara H Braffett; John Maynard; Catherine Cowie; Rose A Gubitosi-Klug; Jeff Way; Karen Anderson; Annette Barnie; Stephan Villavicencio Journal: Diabetes Care Date: 2013-06-28 Impact factor: 19.112